Interestingly, other viruses have also been successfully employed for the same purpose, such as Herpes simplex virus type I with a GM-CSF insertion and deletion of γ34.5 and ICP47 genes, which has been approved by the Food and Drug Administration for advanced melanoma treatment since 2015 [37,38]. Here, CSF2 is linked to melanoma.